Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Motion 3 passed

I heard Cliff quickly say that all three motions (BOD, Accountants, majority vote) passed. I sent in a written question which was answered and confirmed that the shareholder-initiated Motion 3 (for which the BOD indicated AGAINST) was indeed approved.
This was to "amend the PTSC charter documents to provide for the election of directors by majority vote".

The BOD recommended "AGAINST".
So who had enough shares to override the BOD and its proxies etc?
Did the common stockholders finally win one?

Is there a way to get the actual vote counts published?

Share
New Message
Please login to post a reply